# Dexorgen Inc.

Canonical: https://abierto.us/vendors/dexorgen-inc-znumj4fkrc19

- UEI: ZNUMJ4FKRC19
- CAGE: 62JZ3
- Location: Gaithersburg, MD
- Awards in window: 6 (6 transactions), $24,900 obligated, February 26, 2024 to February 6, 2026

## Awarding agencies

- National Institutes of Health: 6 awards, $24,900

## Industries

- 541380 Testing Laboratories and Services: $36,540
- 541990 All Other Professional, Scientific, and Technical Services: $13,200
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0
- 325414 Biological Product (except Diagnostic) Manufacturing: -$24,840

## Competition

- Not Competed Under SAP: 3 awards
- Not Competed: 2 awards
- Full and Open Competition After Exclusion of Sources: 1 awards

## Solicitations won

- HTLV ENVELOPE PROTEIN PRODUCTION SERVICES (AMBIS 2225428) (NOI-NIAID-24-2225428). https://abierto.us/opportunities/noiniaid242225428

## Largest awards

- 75N93024P00784 (purchase order): $25,770, National Institutes of Health Niaid. HTLV Envelope Protein Production Services (Ambis #2225428). https://www.usaspending.gov/award/CONT_AWD_75N93024P00784_7529_-NONE-_-NONE-/
- 75N95024P00487 (purchase order): $24,000, National Institutes of Health Nida. Generation and Characterization Ipsc Derived Brain Organoids from Bain Type X-Linked Mental Retardation Syndrome (Mrxsb). https://www.usaspending.gov/award/CONT_AWD_75N95024P00487_7529_-NONE-_-NONE-/
- 75N95C25P00106 (purchase order): $13,200, National Institutes of Health Ncats. Develop and Optimize Antagonists Assays in Acvr1-Wt, Acvr1-R206h,acvr1-T283i and Acvr1-R206h-T283i Cells. https://www.usaspending.gov/award/CONT_AWD_75N95C25P00106_7529_-NONE-_-NONE-/
- 75N94019C00010 (definitive contract): $0, National Institutes of Health Nichd. EO14042 Development of Novel Pde4b Inhibitors to Treat Alcohol Use Disorder SBIR Phase II. https://www.usaspending.gov/award/CONT_AWD_75N94019C00010_7529_-NONE-_-NONE-/
- 75N95020P00200 (purchase order): -$13,230, National Institutes of Health Nida. Production of Recombinant Coronavirus Main Protease Enzymes.. https://www.usaspending.gov/award/CONT_AWD_75N95020P00200_7529_-NONE-_-NONE-/
- 75N93021P01316 (purchase order): -$24,840, National Institutes of Health Niaid. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N93021P01316_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/dexorgen-inc-znumj4fkrc19.